Background Atrial cardiopathy (AC) and patent foramen ovale (PFO) are two etiologies of
embolic strokes of undetermined source (ESUS). We aimed to explore the relationship …

Patent foramen ovale (PFO) is a frequent echocardiographic finding and can be found in
approximately 15-25% of the general population (Fig. 1) 1. The incidence of PFO is 2-to 3 …

Background Embolic stroke of undetermined source (ESUS) accounts for a substantial
proportion of ischaemic strokes. A stroke recurrence score has been shown to predict the …

Background High-risk patent foramen ovale (PFO) could be pathological in cryptogenic
stroke (CS), but its clinical characteristics have not been fully studied, especially in elderly …

Cryptogenic infarctions are infarctions without a defined cause, despite a complete work-up.
They differ from infarctions of undetermined causes, which may involve overlapping causes …

Materials and Methods: We performed a single-center study of ambispective nature. Patients
above 18 years of age with a diagnosis of cryptogenic (ESUS) strokes from January 1, 2017 …

Background Calcium deposits in the heart have been associated with cardiovascular events,
mortality, stroke, and atrial fibrillation (AF). However, there is no accepted standard method …

A State of the Art lecture titled “Cancer and Arterial Thrombosis: Therapeutic Options” was
presented at the International Society on Thrombosis and Haemostasis Congress in 2023 …

Embolic stroke of unknown source (ESUS) is currently thought to represent a subpopulation
of cryptogenic strokes defined by its embolic stroke pattern on imaging, and if after a …

Background: In patients with embolic stroke of undetermined source (ESUS), occult atrial
fibrillation (AF) has been implicated as a key source of cardioembolism. However, only a …